HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 613-624 of 1,811
Drug study icon
CompletedNCT01074294

Safety and Efficacy of OPC-34712 for ADHD

Official study title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adult Attention Deficit/ Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00334880

Safety study of Safety and Efficacy of NRP104 in ADHD

What is this study about?

This study evaluated the safety and effectiveness of NRP104 for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
New River Pharmaceuticals
Drug study icon
CompletedNCT00783835

Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

A Multicenter Open Trial to Evaluate the Effectiveness and Quality of Life in Adults With Attention Deficit /Hyperactivity Disorder (ADHD) Treated With Long Acting Methylphenidate (CONCERTA)

This study has finished and is no longer accepting participants.

Multiple locations, including Belo Horizonte
ADHDMedication studyAges 18–65
Countries
Brazil
Sponsor
Janssen-Cilag Farmaceutica Ltda.
Other study type icon
CompletedNCT04326543

Temperament Dimensions and Awakening Salivary Cortisol Levels in ADHD.

Official study title

Association Between Temperament Dimensions and Awakening Salivary Cortisol Levels in Children and Adolescents With Attention Deficit Hyperactivity/Impulsivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In Sassari
ADHDObservational studyAges 3–16
Countries
Italy
Sponsor
Università degli Studi di Sassari
Other study type icon
CompletedNCT00418184

Phosphatidylserine-Omega3 for ADHD

Official study title

A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Petach-Tiqva
ADHDPlacebo comparisonAges 6–13
Countries
Israel
Sponsor
Enzymotec

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.